Structural changes of myocardium in patients with diabetes mellitus 2 type and cardiac autonomic neuropathy
DOI:
https://doi.org/10.21856/j-PEP.2018.1.02Keywords:
type 2 diabetes mellitus, arterial hypertension, remodeling, cardiac autonomic neuropathyAbstract
Cardiovascular disease is the main cause of mortality in type 2 diabetes patients. There is an increasing number of evidence that cardiac autonomic neuropathy is a prognostically important factor and marker for increasing mortality from cardiovascular disease. In turn, the remodeling of the myocardium leads to more frequent cardiovascular complications in patients with type 2 diabetes. The purpose of this work is to investigate the relationship between echocardiographic characteristics of the myocardium and signs of cardiac autonomic neuropathy in patients with type 2 diabetes. 19 patients with type 2 diabetes and arterial hypertension were examined. Structural characteristics of the myocardium were evaluated using echocardiography; cardiac autonomic neuropathy was diagnosed using standard Ewing tests. The obtained results demonstrate the existence of a relationship between the signs of cardiac autonomic neuropathy and echocardiographic characteristics of the myocardium in patients with type 2 diabetes mellitus.
References
International Diabetes Federation: Diabetes Atlas. 7th Ed.2015.
American Diabetes Association. Standarts of medical care in diabetes, 2017.
Koval’ SN, et al. Vnutrishnja Medycyna 2009; 3: 71-76.
Koren MJ, Devereux RB, Casale PN, et al. Ann Intern Med 1991; 114: 345-352. doi: http://doi.org/10.7326/0003-4819-114-5-345
Bartni RM, Malmberg K, Ryden L. Eur Heart J 2003;5: 33-41. doi: http://doi.org/10.1016/S1388-9842(02)00177-0
Ewing DJ, Martyn CN, Young RJ, et al. Diabetes Care 1985; 8: 491-498. doi: http://doi.org/10.2337/diacare.8.5.491
Kahn R. Diabetes Care 1992; 15(3): 1095-1103.
Fisher VL, Tahrani AA. Diab Metab Syndrome Obes 2017; 10: 419-434. doi: http://doi.org/10.2147/DMSO.S129797
Ganau A, Devereux RB, Roman MJ, et al. J Am Coll Cardio 1992; 19: 1550-1558. doi: http://doi.org/10.1016/0735-1097(92)90617-V
Devereux RB, Reichek N. Circulation 1997; 55: 613-618. doi: http://doi.org/10.1161/01.CIR.55.4.613
Mancia G., De Backer G., Dominiczak A, et al. Eur Heart J 2007; 28(12): 1462-1536.
Spallone V, Ziegler D, Freeman R, et al. Diabetes Metab Res Rev 2011; 7: 639-653. doi: http://doi.org/10.1002/dmrr.1239
Pop-Busui R, Cleary PA, Braffett BH, et al. J Am Coll Cardiol 2013; 4: 447-454. doi: http://doi.org/10.1016/j.jacc.2012.10.028
Gambardella S, Frontoni S, Spallone V. Am J Hypertens 1993; 6(2): 97-102.doi: http://doi.org/10.1093/ajh/6.2.97
Bellmann B, Tschöpe C. Herz 2014; 9(3): 306-311.doi: http://doi.org/10.1007/s00059-014-4093-2